|
|||||
![]() |
|
Generated record Q1 Contribution ex-TAC and programmatic revenue, driven by 40% year-over-year CTV revenue growth, alongside a 95% year-over-year increase in Adjusted EBITDA
Trading structure simplification has driven higher trading volume as well as increased analyst and investor interest
Completed $50 million Ordinary Share repurchase program and launched a new and ongoing $50 million repurchase program in April 2025
Hosting investor day on May 22, 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, announced today its financial results for the three months ended March 31, 2025.
Q1 2025 Financial Highlights
“Our momentum continued in Q1 fueling record results driven by CTV, alongside significant Adjusted EBITDA growth,” said Ofer Druker, Chief Executive Officer of Nexxen. “We believe these results reflect the payoff from years of investment in our technology, data capabilities and brand. Industry partners are increasingly embracing our full stack of interconnected AI-powered data and technology solutions - driving greater spending, deeper adoption and long-term growth potential, even in uncertain market conditions. The recent launch of nexAI, which is already being utilized by dozens of clients, marks an exciting step forward in our innovation journey - maximizing data value, improving usability and enhancing performance for customers across their workflows through a suite of AI-powered assistants and features. We remain confident these innovative advancements will increase our competitive advantages, further our momentum, accelerate our growth opportunity and reinforce our leadership position, and we look forward to sharing more at our investor day next week.”
Financial Guidance
Operational Highlights
Share Repurchase Program Updates (Share Totals and Cost Basis’ Shown on a Post-Reverse-Split Basis)
Financial Highlights for the Three Months Ended March 31, 2025 ($ in millions, except per share amounts)
Three months ended March 31 | ||||||||||
2025 | 2024 | % | ||||||||
IFRS highlights | ||||||||||
Revenue | 78.3 | 74.4 | 5% | |||||||
Programmatic revenue | 71.8 | 65.6 | 10% | |||||||
Operating profit (loss) | 3.4 | (6.6) | 153% | |||||||
Net income (loss) margin on a gross profit basis | 3% | (14%) | ||||||||
Total comprehensive income (loss) | 2.4 | (7.3) | 133% | |||||||
Diluted earnings (loss) per share (*) | 0.02 | (0.10) | 126% | |||||||
Non-IFRS highlights | ||||||||||
Contribution ex-TAC | 75.0 | 69.7 | 8% | |||||||
Adjusted EBITDA | 23.1 | 11.9 | 95% | |||||||
Adjusted EBITDA Margin on a Contribution ex-TAC basis | 31% | 17% | ||||||||
Non-IFRS net income | 10.6 | 1.2 | 808% | |||||||
Non-IFRS diluted earnings per share (*) | 0.16 | 0.02 | 898% | |||||||
(*) Prior period results have been retroactively adjusted to reflect the Company’s two-for-one reverse share split and the changes in par value from NIS 0.01 to NIS 0.02 effected on February 14, 2025. See also Note 1a of the Company’s Annual Report on Form 20-F filed on March 5, 2025 for details.
First Quarter 2025 Financial Results Webcast and Conference Call Details
About Nexxen
Nexxen empowers advertisers, agencies, publishers and broadcasters around the world to utilize data and advanced TV in the ways that are most meaningful to them. Our flexible and unified technology stack comprises a demand-side platform (“DSP”) and supply-side platform (“SSP”), with the Nexxen Data Platform at its core. With streaming in our DNA, Nexxen’s robust capabilities span discovery, planning, activation, monetization, measurement and optimization – available individually or in combination – all designed to enable our partners to achieve their goals, no matter how far-reaching or hyper niche they may be.
Nexxen is headquartered in Israel and maintains offices throughout the United States, Canada, Europe and Asia-Pacific, and is traded on Nasdaq (NEXN). For more information, visit www.nexxen.com.
For further information please contact:
Billy Eckert, Vice President of Investor Relations
[email protected]
Caroline Smith, Vice President of Communications
[email protected]
Forward Looking Statements
This press release contains forward-looking statements, including forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended. Forward-looking statements are identified by words such as “anticipates,” “believes,” “expects,” “intends,” “may,” “can,” “will,” “estimates,” and other similar expressions. However, these words are not the only way Nexxen identifies forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding anticipated financial results for full year 2025 and beyond; anticipated benefits of Nexxen’s strategic transactions and commercial partnerships; anticipated features and benefits of Nexxen’s products and service offerings, including anticipated benefits relating to the launch of nexAI; Nexxen’s positioning for accelerated growth and continued future growth; Nexxen’s medium- to long-term prospects; management’s belief that Nexxen is well-positioned to benefit from future industry growth trends and Company-specific catalysts; the Company’s plans with respect to its cash reserves as well as ongoing and future share repurchase programs; the anticipated impact of the Company’s Generative AI initiative and its ability to contribute to the Company’s growth; management’s expectations to continue investments in technology, data and Generative AI throughout 2025, and the anticipated impact of these investments; as well as any other statements related to Nexxen’s future financial results and operating performance. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties and other important factors that may cause Nexxen’s actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements, including, but not limited to, the following: negative global economic conditions, including risks related to tariff impacts or policy shifts (including trade negotiations or enforcement actions) that could materially affect market sentiment, consumer behavior and advertising demand; global conflicts and war, including the war and hostilities between Israel and Hamas, Hezbollah, the Houthis in Yemen and Iran, and how those conditions may adversely impact Nexxen’s business, customers and the markets in which Nexxen competes; changes in industry trends; and other negative developments in Nexxen’s business or unfavorable legislative or regulatory developments. Nexxen cautions you not to place undue reliance on these forward-looking statements. For a more detailed discussion of these factors, and other factors that could cause actual results to vary materially, interested parties should review the risk factors listed in the Company’s most recent Annual Report on Form 20-F, filed with the U.S. Securities and Exchange Commission (www.sec.gov) on March 5, 2025. Any forward-looking statements made by Nexxen in this press release speak only as of the date of this press release, and Nexxen does not intend to update these forward-looking statements after the date of this press release, except as required by law.
Nexxen, and the Nexxen logo are trademarks of Nexxen International Ltd. in the United States and other countries. All other trademarks are the property of their respective owners. The use of the word “partner” or “partnership” in this press release does not mean a legal partner or legal partnership.
Use of Non-IFRS Financial Information
In addition to our IFRS results, we review certain non-IFRS financial measures to help us evaluate our business, measure our performance, identify trends affecting our business, establish budgets, measure the effectiveness of investments in our technology and development and sales and marketing, and assess our operational efficiencies. These non-IFRS measures include Contribution ex-TAC, Adjusted EBITDA, Adjusted EBITDA Margin, Non-IFRS Net Income and Non-IFRS Earnings per share, each of which is discussed below.
These non-IFRS financial measures are not intended to be considered in isolation from, as substitutes for, or as superior to the corresponding financial measures prepared in accordance with IFRS. You are encouraged to evaluate these adjustments and review the reconciliation of these non-IFRS financial measures to their most comparable IFRS measures and the reasons we consider them appropriate. It is important to note that the particular items we exclude from, or include in, our non-IFRS financial measures may differ from the items excluded from, or included in, similar non-IFRS financial measures used by other companies. See "Reconciliation of Revenue to Contribution ex-TAC," "Reconciliation of Total Comprehensive Income (Loss) to Adjusted EBITDA," and "Reconciliation of Net Income (Loss) to Non-IFRS Net Income," included as part of this press release.
We do not provide a reconciliation of forward-looking non-IFRS financial metrics because reconciling information is not available without an unreasonable effort, such as attempting to make assumptions that cannot reasonably be made on a forward-looking basis to determine the corresponding IFRS metric.
Reconciliation of Total Comprehensive Income (Loss) to Adjusted EBITDA
Three months ended March 31 | |||||
2025 | 2024 | % | |||
($ in thousands) | |||||
Total comprehensive income (loss) | 2,391 | (7,286) | 133% | ||
Foreign currency translation differences for foreign operation | (758) | 412 | |||
Tax expenses (benefit) | 2,876 | (225) | |||
Financial income (expenses), net | (1,060) | 545 | |||
Depreciation and amortization | 15,267 | 15,793 | |||
Stock-based compensation expenses | 2,900 | 2,634 | |||
Delisting related one-time costs | 1,520 | - | |||
Adjusted EBITDA | 23,136 | 11,873 | 95% |
Reconciliation of Revenue to Contribution ex-TAC
Three months ended March 31 | |||||
2025 | 2024 | % | |||
($ in thousands) | |||||
Revenue | 78,330 | 74,432 | 5% | ||
Cost of revenue (exclusive of depreciation and amortization) | (11,199) | (14,538) | |||
Depreciation and amortization attributable to cost of revenue | (12,294) | (11,766) | |||
Gross profit (IFRS) | 54,837 | 48,128 | 14% | ||
Depreciation and amortization attributable to cost of revenue | 12,294 | 11,766 | |||
Cost of revenue (exclusive of depreciation and amortization) | 11,199 | 14,538 | |||
Performance media cost | (3,342) | (4,750) | |||
Contribution ex-TAC (Non-IFRS) | 74,988 | 69,682 | 8% |
Reconciliation of Net Income (Loss) to Non-IFRS Net Income
Three months ended March 31 | |||||
2025 | 2024 | % | |||
($ in thousands) | |||||
Net income (loss) | 1,633 | (6,874) | 124% | ||
Amortization of acquired intangibles | 5,870 | 7,057 | |||
Delisting related one-time costs | 1,520 | - | |||
Stock-based compensation expenses | 2,900 | 2,634 | |||
Tax effect of Non-IFRS adjustments(1) | (1,284) | (1,645) | |||
Non-IFRS net income | 10,639 | 1,172 | 808% | ||
Weighted average shares outstanding—diluted (in millions)(2) (*) | 65.7 | 72.2 | |||
Non-IFRS diluted earnings per share (in USD) (*) | 0.16 | 0.02 | 898% | ||
(1) Non-IFRS net income includes the estimated tax impact from the expense items reconciling between net income (loss) and non-IFRS net income
(2) Non-IFRS earnings per share is computed using the same weighted-average number of shares that are used to compute IFRS earnings (loss) per share
(*) Prior period results have been retroactively adjusted to reflect the Company’s two-for-one reverse share split and the changes in par value from NIS 0.01 to NIS 0.02 effected on February 14, 2025. See also Note 1a of the Company’s Annual Report on Form 20-F filed on March 5, 2025 for details.
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL POSITION (Unaudited) | |||
March 31 | December 31 | ||
2025 | 2024 | ||
USD thousands | |||
Assets | |||
ASSETS: | |||
Cash and cash equivalents | 164,712 | 187,068 | |
Trade receivables, net | 159,182 | 217,960 | |
Other receivables | 6,407 | 4,579 | |
Current tax assets | 3,987 | 3,373 | |
TOTAL CURRENT ASSETS | 334,288 | 412,980 | |
Fixed assets, net | 16,181 | 15,727 | |
Right-of-use assets | 28,790 | 31,500 | |
Intangible assets, net | 332,336 | 336,768 | |
Deferred tax assets | 14,474 | 17,800 | |
Investment in shares | 25,000 | 25,000 | |
Other long-term assets | 572 | 738 | |
TOTAL NON-CURRENT ASSETS | 417,353 | 427,533 | |
TOTAL ASSETS | 751,641 | 840,513 | |
Liabilities and shareholders’ equity | |||
LIABILITIES: | |||
Current maturities of lease liabilities | 14,191 | 14,340 | |
Trade payables | 173,049 | 228,514 | |
Other payables | 36,796 | 38,526 | |
Current tax liabilities | 4,247 | 4,677 | |
TOTAL CURRENT LIABILITIES | 228,283 | 286,057 | |
Employee benefits | 275 | 300 | |
Long-term lease liabilities | 19,854 | 22,857 | |
Deferred tax liabilities | 503 | 445 | |
TOTAL NON-CURRENT LIABILITIES | 20,632 | 23,602 | |
TOTAL LIABILITIES | 248,915 | 309,659 | |
SHAREHOLDERS’ EQUITY: | |||
Share capital | 360 | 377 | |
Share premium | 332,005 | 362,507 | |
Other comprehensive loss | (1,718) | (2,476) | |
Retained earnings | 172,079 | 170,446 | |
TOTAL SHAREHOLDERS’ EQUITY | 502,726 | 530,854 | |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 751,641 | 840,513 |
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATION AND OTHER COMPREHENSIVE INCOME (LOSS) (Unaudited) | |||
Three months ended March 31 | |||
2025 | 2024 | ||
USD thousands | |||
Revenue | 78,330 | 74,432 | |
Cost of Revenue (Exclusive of depreciation and amortization shown separately below) | 11,199 | 14,538 | |
Research and development expenses | 12,764 | 12,381 | |
Selling and marketing expenses | 28,866 | 27,134 | |
General and administrative expenses | 6,785 | 11,140 | |
Depreciation and amortization | 15,267 | 15,793 | |
Total operating costs | 63,682 | 66,448 | |
Operating Profit (loss) | 3,449 | (6,554) | |
Financing income | (1,770) | (2,425) | |
Financing expenses | 710 | 2,970 | |
Financing expenses (income), net | (1,060) | 545 | |
Profit (loss) before taxes on income | 4,509 | (7,099) | |
Tax expenses (benefits) | 2,876 | (225) | |
Profit (loss) for the period | 1,633 | (6,874) | |
Other comprehensive income (loss) items: | |||
Foreign currency translation differences for foreign operation | 758 | (412) | |
Total other comprehensive income (loss) for the period | 758 | (412) | |
Total comprehensive income (loss) for the period | 2,391 | (7,286) | |
Loss per share | |||
Basic earnings (loss) per share (in USD) (*) | 0.03 | (0.10) | |
Diluted earnings (loss) per share (in USD) (*) | 0.02 | (0.10) | |
(*) Prior period results have been retroactively adjusted to reflect the Company’s two-for-one reverse share split and the changes in par value from NIS 0.01 to NIS 0.02 effected on February 14, 2025. See also Note 1a of the Company’s Annual Report on Form 20-F filed on March 5, 2025 for details.
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN EQUITY (Unaudited) | |||||||||
Share capital | Share premium | Other comprehensive income (loss) | Retained earnings | Total | |||||
USD thousands | |||||||||
Balance as of January 1, 2025 | 377 | 362,507 | (2,476) | 170,446 | 530,854 | ||||
Total comprehensive income for the period | |||||||||
Profit for the period | - | - | - | 1,633 | 1,633 | ||||
Other comprehensive income: | |||||||||
Foreign currency translation | - | - | 758 | - | 758 | ||||
Total comprehensive income for the period | - | - | 758 | 1,633 | 2,391 | ||||
Transactions with owners, recognized directly in equity | |||||||||
Own shares acquired | (20) | (32,864) | - | - | (32,884) | ||||
Share based compensation | - | 2,203 | - | - | 2,203 | ||||
Exercise of share options | 3 | 159 | - | - | 162 | ||||
Balance as of March 31, 2025 | 360 | 332,005 | (1,718) | 172,079 | 502,726 | ||||
Balance as of January 1, 2024 | 417 | 410,563 | (2,441) | 135,009 | 543,548 | ||||
Total comprehensive loss for the period | |||||||||
Loss for the period | - | - | - | (6,874) | (6,874) | ||||
Other comprehensive loss: | |||||||||
Foreign currency translation | - | - | (412) | - | (412) | ||||
Total comprehensive loss for the period | - | - | (412) | (6,874) | (7,286) | ||||
Transactions with owners, recognized directly in equity | |||||||||
Own shares acquired | (17) | (16,075) | - | - | (16,092) | ||||
Share based compensation | - | 2,660 | - | - | 2,660 | ||||
Exercise of share options | 2 | 189 | - | - | 191 | ||||
Balance as of March 31, 2024 | 402 | 397,337 | (2,853) | 128,135 | 523,021 |
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (Unaudited) | |||
Three months ended March 31 | |||
2025 | 2024 | ||
USD thousands | |||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||
Profit (loss) for the period | 1,633 | (6,874) | |
Adjustments for: | |||
Depreciation and amortization | 15,267 | 15,793 | |
Net financing expense (income) | (1,113) | 430 | |
Gain on leases modification | (9) | (4) | |
Share-based compensation and restricted shares | 2,900 | 2,634 | |
Tax expenses (benefits) | 2,876 | (225) | |
Change in trade and other receivables | 57,122 | 45,684 | |
Change in trade and other payables | (58,640) | (19,361) | |
Change in employee benefits | (23) | (7) | |
Income taxes received | 76 | 453 | |
Income taxes paid | (1,552) | (433) | |
Interest received | 1,266 | 1,961 | |
Interest paid | (528) | (2,325) | |
Net cash provided by operating activities | 19,275 | 37,726 | |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Change in pledged deposits, net | (58) | (27) | |
Payments on finance lease receivable | 390 | 443 | |
Acquisition of fixed assets | (2,274) | (2,719) | |
Acquisition and capitalization of intangible assets | (3,905) | (3,618) | |
Repayment of debt investment | 23 | 27 | |
Net cash used in investing activities | (5,824) | (5,894) | |
CASH FLOWS FROM FINANCING ACTIVITIES | |||
Acquisition of own shares | (31,979) | (15,970) | |
Proceeds from exercise of share options | 162 | 191 | |
Leases repayment | (4,113) | (4,027) | |
Net cash used in financing activities | (35,930) | (19,806) | |
Net increase (decrease) in cash and cash equivalents | (22,479) | 12,026 | |
CASH AND CASH EQUIVALENTS AS OF THE BEGINNING OF PERIOD | 187,068 | 234,308 | |
EFFECT OF EXCHANGE RATE FLUCTUATIONS ON CASH AND CASH EQUIVALENTS | 123 | (1,397) | |
CASH AND CASH EQUIVALENTS AS OF THE END OF PERIOD | 164,712 | 244,937 |
May-14 | |
May-06 | |
May-05 | |
May-01 | |
Apr-30 | |
Apr-25 | |
Apr-24 | |
Apr-21 | |
Apr-18 | |
Apr-10 | |
Apr-01 | |
Mar-19 | |
Mar-13 | |
Mar-05 | |
Feb-19 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite